ENROLLED SENATE
BILL NO. 458 By: Stanley, Green, Hamilton, Young, Murdock,
Coleman, Rogers, Daniels, Paxton, Dahm, Woods, Pederson, Burns, Prieto, and
Bergstrom of the Senate
and
McEntire, Wallace,
Townley, Pfeiffer, Lowe (Dick), Archer, Bennett, Moore, Fetgatter, McDugle,
McBride, Kerbs, Grego, Cantrell, Nichols, Echols, Talley, Strom, and Stark of
the House
An Act relating to the practice of nursing; providing for
independent prescriptive authority of Advanced Practice Registered Nurses who
meet certain requirements; providing certain construction; stating application
criteria; specifying duration of authority; authorizing supervision by Advanced
Practice Registered Nurse with independent prescriptive authority who meets
certain requirements; authorizing Oklahoma Board of Nursing to prescribe
additional qualifications; providing for application approval, denial,
reapplication, fees, and independent prescriptive authority revocation;
amending 59 O.S. 2021, Section 353.1, as amended by Section 6, Chapter 288, O.S.L.
2022 (59 O.S. Supp. 2023, Section 353.1), which relates to definitions used in
the Oklahoma Pharmacy Act; modifying and adding definitions; amending 59 O.S.
2021, Section 353.1a, which relates to prescriptive authority of Advanced
Practice Registered Nurses; modifying prescriptive authority of certain
Advanced Practice Registered Nurses; amending 59 O.S. 2021, Section 567.3a,
which relates to definitions used in the Oklahoma Nursing Practice Act;
modifying and adding definitions; amending 59 O.S. 2021, Section 567.4a, which
relates to prescriptive authority; specifying authority of the Board to grant
prescriptive authority; directing the Board to promulgate certain rules;
modifying references; conforming language; clarifying certain educational
requirement; amending 59 O.S. 2021, Section 567.5a, which relates to Advanced
Practice Registered Nurse license; providing for independent prescriptive
authority by endorsement; amending 63 O.S. 2021, Section 2-312, as amended by
Section 2, Chapter 184, O.S.L. 2022 (63 O.S. Supp. 2023, Section 2-312), which
relates to controlled dangerous substances; conforming language relating to
supervision requirement; updating statutory language; updating statutory
references; providing for codification; and declaring an emergency.
SUBJECT: Practice of nursing
BE IT
ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1.
NEW LAW A new section of law
to be codified in the Oklahoma Statutes as Section 567.4c of Title 59, unless
there is created a duplication in numbering, reads as follows:
A. 1. An Advanced Practice Registered Nurse
recognized by the Oklahoma Board of Nursing as a Certified Nurse Practitioner,
Clinical Nurse Specialist, or Certified Nurse-Midwife who has completed a
minimum of six thousand two hundred forty (6,240) hours of practice with
prescriptive authority supervised by a physician or completed an accredited
residency program may apply to the Oklahoma Board of Nursing for authority to
prescribe and order independent of supervision.
This paragraph shall not be construed to exclude practice hours with supervised
prescriptive authority obtained prior to the effective date of this act from
being counted toward the hours required in this paragraph.
2. The application for
independent prescriptive authority shall include proof that the Certified Nurse
Practitioner, Clinical Nurse Specialist, or Certified Nurse-Midwife:
a. holds
a valid, current license in the appropriate Advanced Practice Registered Nurse
role issued by the Board and is in good standing with the Board, and
b. has
completed a minimum of six thousand two hundred forty (6,240) hours of practice
with prescriptive authority supervised by a physician or completed an
accredited residency program.
3. Independent
prescriptive authority granted under this subsection shall be valid until the
expiration of the current license to practice and may be renewed upon
application to the Board at the same time and for the same period as the
renewal of the license to practice.
B. The Board shall review
any application submitted under this section and shall approve or deny the
application, stating the reason or reasons for denial, if denied. If denied, the applicant may reapply using
the process prescribed by subsection A of this section.
C. The Board may suspend
or revoke independent prescriptive authority granted under this section for
good cause at any time.
D.
The Board may establish a fee for the review of initial and renewal
applications under the provisions of this section.
SECTION 2.
NEW LAW A new section of law
to be codified in the Oklahoma Statutes as Section 567.5b of Title 59, unless
there is created a duplication in numbering, reads as follows:
A. The Oklahoma Board of
Nursing, the State Board of Medical Licensure and Supervision, and the State
Board of Osteopathic Examiners shall collaborate to promulgate a uniform set of
rules:
1. Governing supervision
requirements of an Advanced Practice Registered Nurse who has not obtained
independent prescriptive authority under Section 1 of this act; and
2. That impose a
reasonable limit on the monetary amount that a supervising physician may charge
an Advanced Practice Registered Nurse for supervision. Nothing in this paragraph shall be construed
to require a supervising physician to charge a fee for supervision.
B. The Oklahoma Board of
Nursing, the State Board of Medical Licensure and Supervision, and the State
Board of Osteopathic Examiners may collaborate to promulgate a uniform set of
rules imposing a reasonable limit on the number of Advanced Practice Registered
Nurses that a physician may supervise; provided, however, such rules shall
allow a physician to seek a waiver to exceed this limit for such purposes as
may be determined by the Boards in the uniform set of rules.
C.
The State Board of Medical Licensure and Supervision and the State Board
of Osteopathic Examiners shall make available, and keep updated, in a
conspicuous location on the Internet website of each Board a list of physicians
who are available to supervise Advanced Practice Registered Nurses. The Boards shall develop procedures necessary
for the implementation of this section.
SECTION 3.
NEW LAW A new section of law
to be codified in the Oklahoma Statutes as Section 355.5 of Title 59, unless
there is created a duplication in numbering, reads as follows:
A. A licensed
practitioner, or the employer of the licensed practitioner on his or her
behalf, shall carry malpractice insurance or demonstrate proof of financial
responsibility in a minimum amount of One Million Dollars ($1,000,000.00) per
occurrence and Three Million Dollars ($3,000,000.00) in the aggregate per year.
B. A licensed
practitioner who is employed by or under contract with a federal agency that
carries malpractice insurance in any amount on behalf of the licensed
practitioner shall be deemed in compliance with subsection A of this section
when practicing under such federal employment or contract. However, to the extent the licensed
practitioner practices outside of such federal employment or contract, the
licensed practitioner, or the employer of the licensed practitioner, shall
comply with subsection A of this section.
SECTION 4.
AMENDATORY 59 O.S. 2021,
Section 353.1, as amended by Section 6, Chapter 288, O.S.L. 2022 (59 O.S. Supp.
2023, Section 353.1), is amended to read as follows:
Section 353.1. For the
purposes of the Oklahoma Pharmacy Act:
1. "Accredited program" means
those seminars, classes, meetings, work projects, and other educational courses
approved by the Board State Board of Pharmacy for purposes of
continuing professional education;
2. "Act" means
the Oklahoma Pharmacy Act;
3. "Administer" means the direct
application of a drug, whether by injection, inhalation, ingestion or any other
means, to the body of a patient;
4. "Assistant pharmacist" means
any person presently licensed as an assistant pharmacist in the State of
Oklahoma this state by the Board pursuant to Section 353.10 of this
title and for the purposes of the Oklahoma Pharmacy Act shall be considered the
same as a pharmacist, except where otherwise specified;
5. "Board" or "State Board" means the
State Board of Pharmacy;
6. "Certify" or
"certification of a prescription" means the review of a filled
prescription by a licensed pharmacist or a licensed practitioner with
dispensing authority to confirm that the medication, labeling, and
packaging of the filled prescription are is accurate and meet all
requirements prescribed by state and federal law. For the purposes of this paragraph, "licensed
practitioner" shall not include optometrists with dispensing authority;
7. "Chemical" means any
medicinal substance, whether simple or compound or obtained through the process
of the science and art of chemistry, whether of organic or inorganic origin;
8. "Compounding" means the
combining, admixing, mixing, diluting, pooling, reconstituting or otherwise
altering of a drug or bulk drug substance to create a drug. Compounding
includes the preparation of drugs or devices in anticipation of prescription
drug orders based on routine, regularly observed prescribing patterns;
9. "Continuing professional education"
means professional, pharmaceutical education in the general areas of the
socioeconomic and legal aspects of health care; the properties and actions of
drugs and dosage forms; and the etiology, characteristics and therapeutics of
the diseased state;
10. "Dangerous drug", "legend drug", "prescription drug" or "Rx Only" means a drug:
a. for
human use subject to 21 U.S.C. 353(b)(1), or
b. is
labeled "Prescription Only", or labeled with the following
statement: "Caution: Federal law restricts this drug except for
to use by or on the order of a licensed veterinarian.";
11. "Director"
means the Executive Director of the State Board of Pharmacy unless context
clearly indicates otherwise;
12. "Dispense"
or "dispensing" means the interpretation, evaluation, and
implementation of a prescription drug order including the preparation and
delivery of a drug or device to a patient or a patient's agent in a suitable
container appropriately labeled for subsequent administration to, or use by, a
patient. Dispense includes sell,
distribute, leave with, give away, dispose of, deliver or supply;
13. "Dispenser"
means a retail pharmacy, hospital pharmacy, a group of chain pharmacies under
common ownership and control that do not act as a wholesale distributor, or any
other person authorized by law to dispense or administer prescription drugs,
and the affiliated warehouses or distributions of such entities under common
ownership and control that do not act as a wholesale distributor. For the purposes of this paragraph, "dispenser"
dispenser does not mean a person who dispenses only products to be used
in animals in accordance with 21 U.S.C. 360b(a)(5);
14. "Distribute"
or "distribution" means the sale, purchase, trade, delivery,
handling, storage, or receipt of a product, and does not include the dispensing
of a product pursuant to a prescription executed in accordance with 21 U.S.C.
353(b)(1) or the dispensing of a product approved under 21 U.S.C. 360b(b);
provided, taking actual physical possession of a product or title shall not be
required;
15. "Doctor of Pharmacy" means a
person licensed by the Board to engage in the practice of pharmacy. The terms "pharmacist", "D.Ph.",
and "Doctor of Pharmacy" shall be interchangeable and shall have the
same meaning wherever they appear in the Oklahoma Statutes and the rules
promulgated by the Board;
16. "Drug outlet" means all
manufacturers, repackagers, outsourcing facilities, wholesale distributors,
third-party logistics providers, pharmacies, and all other facilities which are
engaged in dispensing, delivery, distribution or storage of dangerous drugs;
17. "Drugs" means all medicinal
substances and preparations recognized by the United States Pharmacopoeia
Pharmacopeia and National Formulary, or any revision thereof, and all
substances and preparations intended for external and/or internal use in the
cure, diagnosis, mitigation, treatment or prevention of disease in humans or
animals and all substances and preparations, other than food, intended to
affect the structure or any function of the body of a human or animals;
18. "Drug sample"
means a unit of a prescription drug packaged under the authority and
responsibility of the manufacturer that is not intended to be sold and is
intended to promote the sale of the drug;
19. "Durable medical
equipment" has the same meaning as provided by Section 2 of this act
Section 375.2 of this title;
20. "Filled prescription" means
a packaged prescription medication to which a label has been affixed which
contains such information as is required by the Oklahoma Pharmacy Act;
21. "Hospital" means any
institution licensed as a hospital by this state for the care and treatment of
patients, or a pharmacy operated by the Oklahoma Department of Veterans
Affairs;
22. "Licensed practitioner"
means:
a. an allopathic physician,
b. an osteopathic
physician,
c. a podiatric
physician,
d. a dentist,
e. a veterinarian or,
f. an optometrist,
or
g. a Certified Nurse
Practitioner, Clinical Nurse Specialist, or Certified Nurse-Midwife who has
obtained independent prescriptive authority under Section 1 of this act,
licensed to
practice and authorized to prescribe dangerous drugs within the scope of practice
of such practitioner;
23. "Manufacturer" or "virtual
manufacturer" means with respect to a product:
a. a
person that holds an application approved under 21 U.S.C. 355 or a license
issued under 42 U.S.C. 262 for such product, or if such product is not the
subject of an approved application or license, the person who manufactured the
product,
b. a
co-licensed partner of the person described in subparagraph a of this
paragraph that obtains the product directly from a person described in this
subparagraph or subparagraph a of this paragraph,
c. an
affiliate of a person described in subparagraph a or b of this paragraph
who receives the product directly from a person described in this subparagraph
or in subparagraph a or b of this paragraph, or
d. a
person who contracts with another to manufacture a product;
24. "Manufacturing" means the
production, preparation, propagation, compounding, conversion or processing of
a device or a drug, either directly or indirectly by extraction from substances
of natural origin or independently by means of chemical or biological synthesis
and includes any packaging or repackaging of the substances or labeling or
relabeling of its container, and the promotion and marketing of such drugs or
devices. The term "manufacturing" manufacturing
also includes the preparation and promotion of commercially available products
from bulk compounds for resale by licensed pharmacies, licensed practitioners
or other persons;
25. "Medical gas" means those
gases including those in liquid state upon which the manufacturer or
distributor has placed one of several cautions, such as "Rx Only", in
compliance with federal law;
26. "Medical gas order" means an
order for medical gas issued by a licensed prescriber;
27. "Medical gas distributor"
means a person licensed to distribute, transfer, wholesale, deliver or sell
medical gases on drug orders to suppliers or other entities licensed to use,
administer or distribute medical gas and may also include a patient or ultimate
user;
28. "Medical gas supplier" means
a person who dispenses medical gases on drug orders only to a patient or
ultimate user;
29. "Medicine" means any drug or
combination of drugs which has the property of curing, preventing, treating,
diagnosing or mitigating diseases, or which is used for that purpose;
30. "Nonprescription drugs"
means medicines or drugs which are sold without a prescription and which are
prepackaged for use by the consumer and labeled in accordance with the
requirements of the statutes and regulations of this state and the federal
government. Such items shall also
include medical and dental supplies and bottled or nonbulk chemicals which are
sold or offered for sale to the general public if such articles or preparations
meet the requirements of the Federal Food, Drug, and Cosmetic Act, 21
U.S.C.A., Section 321 et seq.;
31. "Outsourcing
facility" including "virtual outsourcing facility" means a
facility at one geographic location or address that:
a. is
engaged in the compounding of sterile drugs,
b. has
elected to register as an outsourcing facility, and
c. complies
with all requirements of 21 U.S.C. 353b;
32. "Package"
means the smallest individual saleable unit of product for distribution by a
manufacturer or repackager that is intended by the manufacturer for ultimate
sale to the dispenser of such product.
For the purposes of this paragraph, "individual saleable unit"
means the smallest container of a product introduced into commerce by the
manufacturer or repackager that is intended by the manufacturer or repackager
for individual sale to a dispenser;
33. "Person" means an
individual, partnership, limited liability company, corporation or association,
unless the context otherwise requires;
34. "Pharmacist-in-charge"
or "PIC" means the pharmacist licensed in this state responsible for
the management control of a pharmacy and all other aspects of the practice of pharmacy
in a licensed pharmacy as defined by Section 353.18 of this title;
35. "Pharmacy"
means a place regularly licensed by the State Board of Pharmacy in which
prescriptions, drugs, medicines, chemicals and poisons are compounded or
dispensed or such place where pharmacists practice the profession of pharmacy,
or a pharmacy operated by the Oklahoma Department of Veterans Affairs;
36. "Pharmacy
technician", "technician", "Rx tech", or "tech"
means a person issued a Technician permit by the State Board of Pharmacy to
assist the pharmacist and perform nonjudgmental, technical, manipulative,
non-discretionary functions in the prescription department under the immediate
and direct supervision of a pharmacist;
37. "Poison"
means any substance which when introduced into the body, either directly or by
absorption, produces violent, morbid or fatal changes, or which destroys living
tissue with which such substance comes into contact;
38. "Practice of pharmacy"
means:
a. the
interpretation and evaluation of prescription orders,
b. the
compounding, dispensing, administering and labeling of drugs and devices,
except labeling by a manufacturer, repackager or distributor of nonprescription
drugs and commercially packaged legend drugs and devices,
c. the
participation in drug selection and drug utilization reviews,
d. the
proper and safe storage of drugs and devices and the maintenance of proper
records thereof,
e. the
responsibility for advising by counseling and providing information, where
professionally necessary or where regulated, of therapeutic values, content,
hazards and use of drugs and devices,
f. the
offering or performing of those acts, services, operations or transactions
necessary in the conduct, operation, management and control of a pharmacy, or
g. the
provision of those acts or services that are necessary to provide
pharmaceutical care;
39. "Preparation"
means an article which may or may not contain sterile products compounded in a
licensed pharmacy pursuant to the order of a licensed prescriber;
40. "Prescriber"
means a person licensed in this state who is authorized to prescribe dangerous
drugs within the scope of practice of the person's profession;
41. "Prescription"
means and includes any order for drug or medical supplies written or signed, or
transmitted by word of mouth, telephone or other means of communication:
a. by
a licensed prescriber,
b. under
the supervision of an Oklahoma licensed practitioner, an Oklahoma licensed
advanced practice registered nurse or an Oklahoma licensed by a
physician assistant pursuant to a practice agreement, or
c. (1) under the supervision of a supervising
physician, by a Certified Nurse Practitioner, Clinical Nurse Specialist, or
Certified Nurse-Midwife licensed in this state who has not obtained independent
prescriptive authority under Section 1 of this act, or
(2) by
a Certified Nurse Practitioner, Clinical Nurse Specialist, or Certified
Nurse-Midwife licensed in this state who has obtained independent prescriptive
authority under Section 1 of this act, or
d. by an Oklahoma licensed
wholesaler or distributor as authorized in Section 353.29.1 of this title;
42. "Product"
means a prescription drug in a finished dosage form for administration to a
patient without substantial further manufacturing, such as capsules, tablets,
and lyophilized products before reconstitution.
"Product" does not include blood components intended for
transfusion, radioactive drugs or biologics and medical gas;
43. "Repackager",
including "virtual repackager", means a person who owns or operates
an establishment that repacks and relabels a product or package for further
sale or distribution without further transaction;
44. "Sterile drug"
means a drug that is intended for parenteral administration, an ophthalmic or
oral inhalation drug in aqueous format, or a drug that is required to be sterile
under state and federal law;
45. "Supervising
physician" means an individual holding a current license to practice as a
physician from the State Board of Medical Licensure and Supervision, pursuant
to the provisions of the Oklahoma Allopathic Medical and Surgical Licensure and
Supervision Act, or the State Board of Osteopathic Examiners, pursuant to the
provisions of the Oklahoma Osteopathic Medicine Act, who supervises an
advanced practice registered nurse a Certified Nurse Practitioner,
Clinical Nurse Specialist, or Certified Nurse-Midwife as defined in Section
567.3a of this title who has not obtained independent prescriptive authority
under Section 1 of this act,
and who is
not in training as an intern, resident, or fellow. To be eligible to supervise an advanced
practice registered nurse, such The supervising physician shall
remain in compliance with the rules promulgated by the State Board of Medical
Licensure and Supervision or the State Board of Osteopathic Examiners;
46. "Supportive
personnel" means technicians and auxiliary supportive persons who are
regularly paid employees of a pharmacy who work and perform tasks in the
pharmacy as authorized by Section 353.18A of this title;
47. "Third-party
logistics provider" including "virtual third-party logistics provider"
means an entity that provides or coordinates warehousing, or other logistics
services of a product in interstate commerce on behalf of a manufacturer,
wholesale distributor, or dispenser of a product but does not take ownership of
the product, nor have responsibility to direct the sale or disposition of the
product. For the purposes of this
paragraph, "third-party logistics provider" does not include shippers
and the United States Postal Service;
48. "Wholesale
distributor" including "virtual wholesale distributor" means a
person other than a manufacturer, a manufacturer's co-licensed partner, a
third-party logistics provider, or repackager engaged in wholesale distribution
as defined by 21 U.S.C. 353(e)(4) as amended by the Drug Supply Chain Security
Act;
49. "County jail"
means a facility operated by a county for the physical detention and correction
of persons charged with, or convicted of, criminal offenses or ordinance
violations or persons found guilty of civil or criminal contempt;
50. "State
correctional facility" means a facility or institution that houses a
prisoner population under the jurisdiction of the Department of Corrections;
51. "Unit dose
package" means a package that contains a single dose drug with the name,
strength, control number, and expiration date of that drug on the label; and
52. "Unit of issue
package" means a package that provides multiple doses of the same drug,
but each drug is individually separated and includes the name, lot number, and
expiration date.
SECTION 5. AMENDATORY 59 O.S. 2021, Section 353.1a, is amended
to read as follows:
Section 353.1a. A. Prescribing 1. Prescriptive authority shall be allowed,
under the medical direction of a supervising physician, for an advanced
practice nurse a licensed Advanced Practice Registered Nurse
recognized by the Oklahoma Board of Nursing in one of the following
categories: advanced registered nurse
practitioners, clinical nurse specialists, or certified nurse-midwives as
a Certified Nurse Practitioner, Clinical Nurse Specialist, or Certified
Nurse-Midwife who has not obtained independent prescriptive authority under
Section 1 of this act.
2.
Prescriptive authority shall be allowed, independent of the medical
direction of a supervising physician, for a licensed Advanced Practice
Registered Nurse recognized by the Oklahoma Board of Nursing as a Certified
Nurse Practitioner, Clinical Nurse Specialist, or Certified Nurse-Midwife who
has obtained independent prescriptive authority under Section 1 of this act.
B. The advanced practice
nurse Advanced Practice Registered Nurse may write or sign, or
transmit by word of mouth, telephone or other means of communication an order
for drugs or medical supplies that is intended to be filled, compounded, or
dispensed by a pharmacist. The
supervising physician, if applicable, and the advanced practice nurse
prescribing Advanced Practice Registered Nurse shall be identified at
the time of origination of the prescription and the name of the advanced
practice nurse prescribing Advanced Practice Registered Nurse shall
be printed on the prescription label.
B. C. Pharmacists
may dispense prescriptions for non-controlled prescription drugs authorized by
an advanced practice nurse Advanced Practice Registered Nurse or
physician assistant, not located in Oklahoma this state, provided
that they are licensed in the state in which they are actively prescribing.
C. D. 1. Pharmacists may only dispense prescriptions
for controlled dangerous substances prescribed by an advanced practice nurse
or physician assistant Advanced Practice Registered Nurse licensed
in the State of Oklahoma and supervised by an Oklahoma-licensed practitioner
this state who meets the criteria in paragraph 1 or 2 of subsection A of
this section.
2.
Pharmacists may only dispense prescriptions for controlled dangerous
substances prescribed by a physician assistant licensed in this state pursuant
to a practice agreement.
SECTION 6.
AMENDATORY 59 O.S. 2021,
Section 567.3a, is amended to read as follows:
Section 567.3a. As used
in the Oklahoma Nursing Practice Act:
1.
"Board" means the Oklahoma Board of Nursing;
2.
"The practice of nursing" means the performance of services
provided for purposes of nursing diagnosis and treatment of human responses to
actual or potential health problems consistent with educational
preparation. Knowledge and skill are the
basis for assessment, analysis, planning, intervention, and evaluation used in
the promotion and maintenance of health and nursing management of illness,
injury, infirmity, restoration or optimal function, or death with dignity. Practice is based on understanding the human
condition across the human lifespan and understanding the relationship of the
individual within the environment. This
practice includes execution of the medical regime including the administration
of medications and treatments prescribed by any person authorized by state law
to so prescribe;
3.
"Registered nursing" means the practice of the full scope of
nursing which includes, but is not limited to:
a. assessing
the health status of individuals, families and groups,
b. analyzing
assessment data to determine nursing care needs,
c. establishing
goals to meet identified health care needs,
d. planning
a strategy of care,
e. establishing
priorities of nursing intervention to implement the strategy of care,
f. implementing
the strategy of care,
g. delegating
such tasks as may safely be performed by others, consistent with educational
preparation and that do not conflict with the provisions of the Oklahoma
Nursing Practice Act,
h. providing
safe and effective nursing care rendered directly or indirectly,
i. evaluating
responses to interventions,
j. teaching
the principles and practice of nursing,
k. managing
and supervising the practice of nursing,
l. collaborating
with other health professionals in the management of health care,
m. performing
additional nursing functions in accordance with knowledge and skills acquired
beyond basic nursing preparation, and
n. delegating
those nursing tasks as defined in the rules of the Board that may be performed
by an advanced unlicensed assistive person;
4.
"Licensed practical nursing" means the practice of nursing
under the supervision or direction of a registered nurse, licensed physician or
dentist. This directed scope of nursing
practice includes, but is not limited to:
a. contributing
to the assessment of the health status of individuals and groups,
b. participating
in the development and modification of the plan of care,
c. implementing
the appropriate aspects of the plan of care,
d. delegating
such tasks as may safely be performed by others, consistent with educational
preparation and that do not conflict with the Oklahoma Nursing Practice Act,
e. providing
safe and effective nursing care rendered directly or indirectly,
f. participating
in the evaluation of responses to interventions,
g. teaching
basic nursing skills and related principles,
h. performing
additional nursing procedures in accordance with knowledge and skills acquired
through education beyond nursing preparation, and
i. delegating
those nursing tasks as defined in the rules of the Board that may be performed
by an advanced unlicensed assistive person;
5.
"Advanced Practice Registered Nurse" means a licensed
Registered Nurse:
a. who
has completed an advanced practice registered nursing education program in
preparation for one of four recognized advanced practice registered nurse
Advanced Practice Registered Nurse roles,
b. who
has passed a national certification examination recognized by the Board that
measures the advanced practice registered nurse Advanced Practice
Registered Nurse role and specialty competencies and who maintains
recertification in the role and specialty through a national certification
program,
c. who
has acquired advanced clinical knowledge and skills in preparation for
providing both direct and indirect care to patients; however, the defining
factor for all Advanced Practice Registered Nurses is that a significant
component of the education and practice focuses on direct care of individuals,
d. whose
practice builds on the competencies of Registered Nurses by demonstrating a
greater depth and breadth of knowledge, a greater synthesis of data, and
increased complexity of skills and interventions, and
e. who
has obtained a license as an Advanced Practice Registered Nurse in one of the
following roles: Certified Registered
Nurse Anesthetist, Certified Nurse-Midwife, Clinical Nurse Specialist, or
Certified Nurse Practitioner.
Only those persons who hold a
license to practice advanced practice registered nursing in this state shall
have the right to use the title "Advanced Practice Registered Nurse"
and to use the abbreviation "APRN".
Only those persons who have obtained a license in the following
disciplines shall have the right to fulfill the roles and use the applicable
titles: Certified Registered Nurse
Anesthetist and the abbreviation "CRNA", Certified Nurse-Midwife and
the abbreviation "CNM", Clinical Nurse Specialist and the
abbreviation "CNS", and Certified Nurse Practitioner and the
abbreviation "CNP".
It shall be unlawful for any person
to assume the role or use the title Advanced Practice Registered Nurse or use
the abbreviation "APRN" or use the respective specialty role titles
and abbreviations or to use any other titles or abbreviations that would
reasonably lead a person to believe the user is an Advanced Practice Registered
Nurse, unless permitted by the Oklahoma Nursing Practice Act. Any individual doing so shall be guilty of a
misdemeanor, which shall be punishable, upon conviction, by imprisonment in the
county jail for not more than one (1) year or by a fine of not less than
One Hundred Dollars ($100.00) nor more than One Thousand Dollars ($1,000.00),
or by both such imprisonment and fine for each offense;
6.
"Certified Nurse Practitioner" is means an
Advanced Practice Registered Nurse who performs in an expanded role in the
delivery of health care:
a. consistent
with advanced educational preparation as a Certified Nurse Practitioner in an
area of specialty,
b. functions
within the Certified Nurse Practitioner scope of practice for the selected area
of specialization, and
c. is
in accord with the standards for Certified Nurse Practitioners as identified by
the certifying body and approved by the Board.
A Certified Nurse Practitioner shall
be eligible, in accordance with the scope of practice of the Certified Nurse
Practitioner, to obtain recognition as authorized by the Board to prescribe, as
defined by the rules promulgated by the Board pursuant to this section and
subject to the medical direction of a supervising physician Section
567.4a of this title and Section 1 of this act. This authorization shall not include
dispensing drugs, but shall not preclude, subject to federal regulations, the
receipt of, the signing for, or the dispensing of professional samples to
patients.
The Certified Nurse Practitioner
accepts responsibility, accountability, and obligation to practice in
accordance with usual and customary advanced practice registered nursing
standards and functions as defined by the scope of practice/role definition
statements for the Certified Nurse Practitioner;
7.
a. "Clinical Nurse
Specialist" is means an Advanced Practice Registered Nurse
who holds:
(1) a
master's degree or higher in nursing with clinical specialization preparation
to function in an expanded role,
(2) specialty
certification from a national certifying organization recognized by the Board,
(3) an
Advanced Practice Registered Nurse license from the Board, and
(4) any
nurse holding a specialty certification as a Clinical Nurse Specialist valid on
January 1, 1994, granted by a national certifying organization recognized by
the Board, shall be deemed to be a Clinical Nurse Specialist under the
provisions of the Oklahoma Nursing Practice Act.
b. In
the expanded role, the Clinical Nurse Specialist performs at an advanced
practice level which shall include, but not be limited to:
(1) practicing
as an expert clinician in the provision of direct nursing care to a selected
population of patients or clients in any setting, including private practice,
(2) managing
the care of patients or clients with complex nursing problems,
(3) enhancing
patient or client care by integrating the competencies of clinical practice,
education, consultation, and research, and
(4) referring
patients or clients to other services.
c. A
Clinical Nurse Specialist in accordance with the scope of practice of such
Clinical Nurse Specialist shall be eligible to obtain recognition as authorized
by the Board to prescribe, as defined by the rules promulgated by the Board
pursuant to this section, and subject to the medical direction of a
supervising physician Section 567.4a of this title and Section 1 of this
act. This authorization shall not
include dispensing drugs, but shall not preclude, subject to federal
regulations, the receipt of, the signing for, or the dispensing of professional
samples to patients.
d. The
Clinical Nurse Specialist accepts responsibility, accountability, and
obligation to practice in accordance with usual and customary advanced practice
nursing standards and functions as defined by the scope of practice/role
definition statements for the Clinical Nurse Specialist;
8.
"Nurse-Midwife" is "Certified Nurse-Midwife"
means a nurse who has received an Advanced Practice Registered Nurse
license from the Oklahoma Board of Nursing who possesses evidence of
certification according to the requirements of the American College of
Nurse-Midwives.
A Certified Nurse-Midwife in
accordance with the scope of practice of such Certified Nurse-Midwife shall be
eligible to obtain recognition as authorized by the Board to prescribe, as
defined by the rules promulgated by the Board pursuant to this section and
subject to the medical direction of a supervising physician Section
567.4a of this title and Section 1 of this act. This authorization shall not include the
dispensing of drugs, but shall not preclude, subject to federal regulations,
the receipt of, the signing for, or the dispensing of professional samples to
patients.
The Certified Nurse-Midwife accepts
responsibility, accountability, and obligation to practice in accordance with
usual and customary advanced practice registered nursing standards and
functions as defined by the scope of practice/role definition statements for
the Certified Nurse-Midwife;
9.
"Nurse-midwifery practice" means providing management of care
of normal newborns and women, antepartally, intrapartally, postpartally and
gynecologically, occurring within a health care system which provides for
medical consultation, medical management or referral, and is in accord with the
standards for nurse-midwifery practice as defined by the American College of
Nurse-Midwives;
10.
a. "Certified Registered
Nurse Anesthetist" is an Advanced Practice Registered Nurse who:
(1) is
certified by the National Board of Certification and Recertification for Nurse
Anesthetists as a Certified Registered Nurse Anesthetist within one (1) year
following completion of an approved certified registered nurse anesthetist
Certified Registered Nurse Anesthetist education program, and continues
to maintain such recertification by the National Board of Certification and
Recertification for Nurse Anesthetists, and
(2) administers
anesthesia in collaboration with a medical doctor, an osteopathic physician, a
podiatric physician or a dentist licensed in this state and under conditions in
which timely onsite consultation by such doctor, osteopath, podiatric physician
or dentist is available.
b. A
Certified Registered Nurse Anesthetist, in collaboration with a medical doctor,
osteopathic physician, podiatric physician or dentist licensed in this state,
and under conditions in which timely, on-site consultation by such medical
doctor, osteopathic physician, podiatric physician or dentist is available, shall
be authorized, pursuant to rules adopted by the Oklahoma Board of Nursing, to
order, select, obtain and administer legend drugs, Schedules II through V
controlled substances, devices, and medical gases only when engaged in the
preanesthetic preparation and evaluation; anesthesia induction, maintenance and
emergence; and postanesthesia care. A
Certified Registered Nurse Anesthetist may order, select, obtain and administer
drugs only during the perioperative or periobstetrical period.
c. A
Certified Registered Nurse Anesthetist who applies for authorization to order,
select, obtain and administer drugs shall:
(1) be
currently recognized as a Certified Registered Nurse Anesthetist in this state,
(2) provide
evidence of completion, within the two-year period immediately preceding the
date of application, of a minimum of fifteen (15) units of continuing education
in advanced pharmacology related to the administration of anesthesia as
recognized by the National Board of Certification and Recertification for Nurse
Anesthetists, and
(3) complete
and submit a notarized application, on a form prescribed by the Board,
accompanied by the application fee established pursuant to this section.
d. The
authority to order, select, obtain and administer drugs shall be terminated if
a Certified Registered Nurse Anesthetist has:
(1) ordered,
selected, obtained or administered drugs outside of the Certified Registered
Nurse Anesthetist scope of practice or ordered, selected, obtained or
administered drugs for other than therapeutic purposes, or
(2) violated
any provision of state laws or rules or federal laws or regulations pertaining
to the practice of nursing or the authority to order, select, obtain and
administer drugs.
e. The
Oklahoma Board of Nursing shall notify the State Board of Pharmacy after
termination of or a change in the authority to order, select, obtain and
administer drugs for a Certified Registered Nurse Anesthetist.
f. The
Board shall provide by rule for biennial application renewal and
reauthorization of authority to order, select, obtain and administer drugs for
Certified Registered Nurse Anesthetists.
At the time of application renewal, a Certified Registered Nurse Anesthetist
shall submit documentation of a minimum of eight (8) units of continuing
education, completed during the previous two (2) years, in advanced
pharmacology relating to the administration of anesthesia, as recognized by the
Council on Recertification of Nurse Anesthetists or the Council on
Certification of Nurse Anesthetists National Board of Certification and
Recertification for Nurse Anesthetists.
g. This
paragraph shall not prohibit the administration of local or topical anesthetics
as now permitted by law. Provided
further, nothing in this paragraph shall limit the authority of the Board of
Dentistry to establish the qualifications for dentists who direct the
administration of anesthesia.
h. As
used in this paragraph, "collaboration" means an agreement between a
medical doctor, osteopathic physician, podiatric physician or dentist
performing the procedure or directly involved with the procedure and the
Certified Registered Nurse Anesthetist working jointly toward a common goal
providing services for the same patient.
This collaboration involves the joint formulation, discussion and
agreement of the anesthesia plan by both parties, and the collaborating medical
doctor, osteopathic physician, podiatric physician or dentist performing the
procedure or directly involved with the procedure and that collaborating
physician shall remain available for timely onsite consultation during the
delivery of anesthesia for diagnosis, consultation, and treatment of medical
conditions;
11.
"Supervising physician" means an individual holding a current
license to practice as a physician from the State Board of Medical Licensure
and Supervision or the State Board of Osteopathic Examiners, who supervises a
Certified Nurse Practitioner, a Clinical Nurse Specialist, or a Certified
Nurse-Midwife who has not obtained independent prescriptive authority under
Section 1 of this act, and who is not in training as an intern, resident,
or fellow. To be eligible to
supervise such Advanced Practice Registered Nurse, such The supervising
physician shall remain in compliance with the rules promulgated by the State
Board of Medical Licensure and Supervision or the State Board of Osteopathic
Examiners;
12.
"Supervision of an Advanced Practice Registered Nurse with
prescriptive authority" means overseeing and accepting responsibility for
the ordering and transmission by a Certified Nurse Practitioner, a Clinical
Nurse Specialist, or a Certified Nurse-Midwife who has not obtained
independent prescriptive authority under Section 1 of this act of written,
telephonic, electronic or oral prescriptions for drugs and other medical
supplies, subject to a defined formulary; and
13.
"Advanced Unlicensed Assistant" means any person who has
successfully completed a certified training program approved by the Board that
trains the Advanced Unlicensed Assistant to perform specified technical skills
identified by the Board in acute care settings under the direction and supervision
of the Registered Nurse or Licensed Practical Nurse.
SECTION 7.
AMENDATORY 59 O.S. 2021,
Section 567.4a, is amended to read as follows:
Section 567.4a. The
Oklahoma Board of Nursing may grant prescriptive authority through the Advanced
Practice Registered Nurse license to Certified Nurse Practitioners, Clinical
Nurse Specialists, and Certified Nurse-Midwives who meet the requirements for
prescriptive authority identified by law and in the Board's rules. The rules regarding prescriptive authority
recognition promulgated by the Oklahoma Board of Nursing pursuant to paragraphs
6 through 9, 11 and 12 of this section, Section 567.3a of this title,
and Section 1 of this act shall:
1.
Define the procedure for documenting supervision by a supervising
physician licensed in Oklahoma to practice by the State Board of Medical
Licensure and Supervision or the State Board of Osteopathic Examiners as
defined in Section 567.3a of this title of a Certified Nurse Practitioner,
Clinical Nurse Specialist, or Certified Nurse-Midwife who has not obtained
independent prescriptive authority under Section 1 of this act. Such procedure shall include a written
statement that defines appropriate referral, consultation, and collaboration
between the Advanced Practice Registered Nurse, recognized to prescribe as
defined in paragraphs 6 through 9, 11 and 12 of Section 567.3a of this
title, and the supervising physician.
The written statement shall include a method of assuring availability of
the supervising physician through direct contact, telecommunications or other
appropriate electronic means for consultation, assistance with medical
emergencies, or patient referral. The
written statement shall be part of the initial application and the renewal
application submitted to the Board for recognition for prescriptive authority
for the Advanced Practice Registered Nurse.
Changes to the written statement shall be filed with the Board within
thirty (30) days of the change and shall be effective on filing;
2.
Define the procedure for documenting independent prescriptive
authority for Certified Nurse Practitioners, Clinical Nurse Specialists, and
Certified Nurse-Midwives who have obtained independent prescriptive authority
under Section 1 of this act;
3. Define minimal
requirements for initial application for prescriptive authority which shall
include, but not be limited to, evidence of completion of a minimum of
forty-five (45) contact hours or three (3) academic credit hours of education
in pharmacotherapeutics, clinical application, and use of pharmacological
agents in the prevention of illness, and in the restoration and maintenance of
health in a program beyond basic registered nurse preparation, approved by the
Board. Such contact hours or academic
credits shall be obtained within a time period of three (3) years immediately
preceding the date of application for prescriptive authority;
3. 4. Define minimal
requirements for application for renewal of prescriptive authority which shall
include, but not be limited to, documentation of a minimum of:
a. fifteen
(15) contact hours or one (1) academic credit hour of education in
pharmacotherapeutics, clinical application, and use of pharmacological agents
in the prevention of illness, and in the restoration and maintenance of health
in a program beyond basic registered nurse preparation, and
b. two
(2) hours of education in pain management or two (2) hours of education in
opioid use or addiction, unless the Advanced Practice Registered Nurse has
demonstrated to the satisfaction of the Board that the Advanced Practice
Registered Nurse does not currently hold a valid federal Drug Enforcement
Administration registration number,
approved by the Board, within the two-year period immediately
preceding the effective date of application for renewal of prescriptive
authority;
4. 5. Require that beginning
July 1, 2002, an Advanced Practice Registered Nurse shall demonstrate
demonstrates successful completion of a master's degree or higher in a
clinical nurse specialty one of the following Advanced Practice
Registered Nurse roles:
a. Certified Nurse
Practitioner,
b. Clinical Nurse
Specialist, or
c. Certified
Nurse-Midwife,
in order to be eligible for initial application for prescriptive
authority under the provisions of the Oklahoma Nursing Practice Act;
5. 6. Define the
method for communicating authority to prescribe or termination of same, and the
formulary to the State Board of Pharmacy, all pharmacies, and all
registered pharmacists;
6. 7. Define
terminology used in such rules;
7. 8. Define the
parameters for the prescribing practices of the Advanced Practice Registered
Nurse;
8. 9. Define the
methods for termination of prescriptive authority for the Advanced Practice
Registered Nurse; and
9. 10. a. Establish a Formulary Advisory Council that
shall develop and submit to the Board recommendations for an exclusionary
formulary that shall list drugs or categories of drugs that shall not be
prescribed by an Advanced Practice Registered Nurse recognized to
prescribe by the Oklahoma Board of Nursing.
The Formulary Advisory Council shall also develop and submit to the
Board recommendations for practice-specific prescriptive standards for each
category of Advanced Practice Registered Nurse recognized to prescribe by the
Oklahoma Board of Nursing pursuant to the provisions of the Oklahoma Nursing
Practice Act. The Board shall either
accept or reject the recommendations made by the Council. No amendments to the recommended exclusionary
formulary may be made by the Board without the approval of the Formulary
Advisory Council.
b. The
Formulary Advisory Council shall be composed of twelve (12) members as follows:
(1) four
members, to include a pediatrician, an obstetrician-gynecological physician, a
general internist, and a family practice physician; provided, that three
of such members shall be appointed by the Oklahoma State Medical Association,
and one shall be appointed by the Oklahoma Osteopathic Association,
(2) four
members who are registered pharmacists, appointed by the Oklahoma Pharmaceutical
Association, and
(3) four
members, one of whom shall be a Certified Nurse Practitioner, one of whom shall
be a Clinical Nurse Specialist, one of whom shall be a Certified Nurse-Midwife,
and one of whom shall be a current member of the Oklahoma Board of Nursing, all
of whom shall be appointed by the Oklahoma Board of Nursing.
c. All
professional members of the Formulary Advisory Council shall be in active
clinical practice, at least fifty percent (50%) of the time, within their
defined area of specialty. The members
of the Formulary Advisory Council shall serve at the pleasure of the appointing
authority for a term of three (3) years.
The terms of the members shall be staggered. Members of the Council may serve beyond the
expiration of their term of office until a successor is appointed by the
original appointing authority. A vacancy
on the Council shall be filled for the balance of the unexpired term by the
original appointing authority.
d. Members
of the Council shall elect a chair and a vice-chair vice chair
from among the membership of the Council.
For the transaction of business, at least seven members, with a minimum
of two members present from each of the identified categories of physicians,
pharmacists and advanced practice registered nurses Advanced Practice
Registered Nurses, shall constitute a quorum. The Council shall recommend and the Board
shall approve and implement an initial exclusionary formulary on or before
January 1, 1997. The Council and the
Board shall annually review the approved exclusionary formulary and shall make
any necessary revisions utilizing the same procedures used to develop the
initial exclusionary formulary.
SECTION 8.
AMENDATORY 59 O.S. 2021,
Section 567.5a, is amended to read as follows:
Section 567.5a. A. All applicants for a license to practice as
an Advanced Practice Registered Nurse shall be subject to Section 567.8 of this
title.
B. An applicant for an
initial license to practice as an Advanced Practice Registered Nurse shall:
1. Submit a completed
written application and appropriate fees as established by the Oklahoma
Board of Nursing;
2. Submit a criminal
history records check that complies with Section 567.18 of this title;
3. Hold a current
Registered Nurse license in this state;
4. Have completed an
advanced practice registered nursing education program in one of the four advanced
practice registered nurse Advanced Practice Registered Nurse roles
and a specialty area recognized by the Board.
Effective January 1, 2016, the applicant shall have completed an
accredited graduate level advanced practice registered nursing education
program in at least one of the following population foci: family/individual across the lifespan,
adult-gerontology, neonatal, pediatrics, women's health/gender-related, or
psychiatric/mental health;
5. Be currently certified
in an advanced practice specialty certification consistent with educational
preparation and by a national certifying body recognized by the Board; and
6. Provide any and all
other evidence as required by the Board in its rules.
C. The Board may issue a
license by endorsement to an Advanced Practice Registered Nurse licensed under
the laws of another state if the applicant meets the qualifications for
licensure in this state. An applicant by
endorsement shall:
1. Submit a completed
written application and appropriate fees as established by the Board;
2. Hold a current
Registered Nurse license in this state;
3. Hold recognition as an
Advanced Practice Registered Nurse in a state or territory;
4. Have completed an
advanced practice registered nursing education program in one of the four roles
and a specialty area recognized by the Board.
Effective January 1, 2016, the applicant shall have completed an
accredited graduate level advanced practice registered nursing education
program in at least one of the following population foci: family/individual across the lifespan,
adult-gerontology, neonatal, pediatrics, women's health/gender-related, or
psychiatric/mental health;
5. Be currently certified
in an advanced practice specialty certification consistent with educational
preparation and by a national certifying body recognized by the Board;
6. Meet continued
competency requirements as set forth in Board rules; and
7. Provide any and all
other evidence as required by the Board in its rules.
D. The Board may issue
prescriptive authority recognition by endorsement to an Advanced Practice
Registered Nurse licensed as an APRN-CNP, APRN-CNS, or APRN-CNM under the laws
of another state if the applicant meets the requirements set forth in this
section. An applicant for prescriptive
authority recognition by endorsement shall:
1. Submit a completed
written application and appropriate fees as established by the Board;
2. Hold current
Registered Nurse and Advanced Practice Registered Nurse licenses (APRN-CNP,
APRN-CNS, or APRN-CNM) in the state;
3. Hold current licensure
or recognition as an Advanced Practice Registered Nurse in the same role and
specialty with prescribing privileges in another state or territory;
4. Submit documentation
verifying successful completion of a graduate level advanced practice
registered nursing education program that included an academic course in
pharmacotherapeutic management, and didactic and clinical preparation for
prescribing incorporated throughout the program;
5. Submit a written
statement from an Oklahoma licensed physician supervising prescriptive
authority as required by the Board in its rules, or submit documentation
that the applicant meets the requirements for independent prescriptive
authority under Section 1 of this act;
6. Meet continued
competency requirements as set forth in Board rules; and
7. Provide any and all
other evidence as required by the Board in its rules.
E. An Advanced Practice Registered
Nurse license issued under this section shall be renewed concurrently with the
registered nurse license, provided that qualifying criteria continue to
be met.
F. The Board may
reinstate a license as set forth in Board rules.
SECTION 9.
AMENDATORY 63 O.S. 2021,
Section 2-312, as amended by Section 2, Chapter 184, O.S.L. 2022 (63 O.S. Supp.
2023, Section 2-312), is amended to read as follows:
Section 2-312. A. A physician, podiatrist, optometrist or a
dentist who has complied with the registration requirements of the Uniform
Controlled Dangerous Substances Act, in good faith and in the course of such
person's professional practice only, may prescribe and administer controlled
dangerous substances, or may cause the same to be administered by medical or
paramedical personnel acting under the direction and supervision of the
physician, podiatrist, optometrist or dentist, and only may dispense controlled
dangerous substances pursuant to the provisions of Sections 355.1 and 355.2 of
Title 59 of the Oklahoma Statutes.
B.
A veterinarian who has complied with the registration requirements of
the Uniform Controlled Dangerous Substances Act, in good faith and in the
course of the professional practice of the veterinarian only, and not for use
by a human being, may prescribe, administer, and dispense controlled dangerous
substances and may cause them to be administered by an assistant or orderly
under the direction and supervision of the veterinarian.
C.
1. An advanced practice
nurse Advanced Practice Registered Nurse who is recognized to
prescribe by the Oklahoma Board of Nursing as an advanced registered nurse
practitioner, clinical nurse specialist or certified nurse-midwife, a
Certified Nurse Practitioner, Clinical Nurse Specialist, or Certified
Nurse-Midwife but who has not obtained independent prescriptive
authority under Section 1 of this act and therefore is subject to medical
direction by a supervising physician, pursuant to Section 567.3a of Title 59 of
the Oklahoma Statutes, and who has complied with the registration requirements
of the Uniform Controlled Dangerous Substances Act, in good faith and in the
course of professional practice only, may prescribe and administer Schedule
III, IV and V controlled dangerous substances.
2.
An Advanced Practice Registered Nurse who is recognized to prescribe by
the Oklahoma Board of Nursing as a Certified Nurse Practitioner, Clinical Nurse
Specialist, or Certified Nurse-Midwife who has obtained independent
prescriptive authority under Section 1 of this act, and who has complied with
the registration requirements of the Uniform Controlled Dangerous Substances
Act, in good faith and in the course of professional practice only, may
prescribe and administer Schedule III, IV, and V controlled dangerous
substances.
D.
An advanced practice nurse Advanced Practice Registered Nurse
who is recognized to order, select, obtain and administer drugs by the Oklahoma
Board of Nursing as a certified registered nurse anesthetist Certified
Registered Nurse Anesthetist pursuant to Section 353.1b of Title 59 of the
Oklahoma Statutes and who has complied with the registration requirements of
the Uniform Controlled Dangerous Substances Act, in good faith and in the
course of such practitioner's professional practice only, may order, select,
obtain and administer Schedules II through V controlled dangerous substances in
a preanesthetic preparation or evaluation; anesthesia induction, maintenance or
emergence; or postanesthesia care setting only.
A certified registered nurse anesthetist Certified Registered
Nurse Anesthetist may order, select, obtain and administer such drugs only
during the perioperative or periobstetrical period.
E.
A physician assistant who is recognized to prescribe by the State Board
of Medical Licensure and Supervision under the medical direction of a
supervising physician, pursuant to Section 519.6 of Title 59 of the Oklahoma
Statutes, and who has complied with the registration requirements of the
Uniform Controlled Dangerous Substances Act, in good faith and in the course of
professional practice only, may prescribe and administer Schedule II through V
controlled dangerous substances.
SECTION 10. It being immediately necessary for the preservation of the public peace, health or safety, an emergency is hereby declared to exist, by reason whereof this act shall take effect and be in full force from and after its passage and approval.
Passed the Senate the 19th day of March, 2024.
Presiding Officer of the Senate
Passed the House of Representatives the 13th day of February, 2024.
Presiding Officer of the House
of Representatives
OFFICE OF THE GOVERNOR
Received
by the Office of the Governor this ____________________ day of
___________________, 20_______, at _______ o'clock _______ M.
By: _________________________________
Approved
by the Governor of the State of Oklahoma this _________ day of
___________________, 20_______, at _______ o'clock _______ M.
_________________________________
Governor of the State of Oklahoma
OFFICE OF THE SECRETARY OF STATE
Received
by the Office of the Secretary of State this __________ day of
__________________, 20 _______, at _______ o'clock _______ M.
By: _________________________________